Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Alfresa Holdings's Enterprise Value is 円266,539 Mil.
Alfresa Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil. Therefore, Alfresa Holdings's EV-to-FCF for today is .
The historical rank and industry rank for Alfresa Holdings's EV-to-FCF or its related term are showing as below:
TSE:2784'
s EV-to-FCF Range Over the Past 10 Years
Min: 0 Med: 0 Max: 25.41
Current: 25.41
During the past 13 years, the highest EV-to-FCF of Alfresa Holdings was 25.41. The lowest was 0.00. And the median was 0.00.
TSE:2784's EV-to-FCF is ranked worse than 64.38% of 73
companies
in the Medical Distribution industry
Industry Median: 17.47
vs TSE:2784: 25.41
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Alfresa Holdings's PE Ratio (TTM) for today is calculated as:
Alfresa Holdings's share price for today is 円2414.00.
Alfresa Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円229.640.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Alfresa Holdings EV-to-FCF Related Terms
Alfresa Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Alfresa Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Alfresa Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alfresa Holdings EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Alfresa Holdings's EV-to-FCF falls into.
Alfresa Holdings's current Enterprise Value is 円266,539 Mil.
Alfresa Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is Alfresa Holdings (TSE:2784) Overvalued in 2026?
Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued.
The current stock price of 円2,414.00 is trading 5.1% below its estimated GF Value™ of 円2,542.44.
GuruFocus considers Alfresa Holdings to be Fairly Valued.
Key valuation signals for TSE:2784:
EV-to-FCF:
GF Value™: 円2,542.44 vs. price of 円2,414.00 (5.1% below fair value)
No single metric tells the full story. See the TSE:2784 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
83GF Score
Get the complete analysis for TSE:2784
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2784 has been successfully added to your 
